Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finances

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon May 06, 2023 4:35am

213 Views

Post# 35434369

RE:RE:RE:RE:RE:RE:RE:RE:RE:Finances

The company has worked on fumes before but realistically, how much is left in the bank now? That 1,5M must be drained very thin. Any raise at these prices will sting, so I wish it won't be a big one. Perhaps after the next data update?

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?